News Daily News Meta-analysis of Pivotal SGLT2 Inhibitor Trials Boosts Hopes in HFpEF L.A. McKeown December 07, 2021
News Conference News AHA 2021 Risk-Based EHR Alert Doesn’t Improve HF Care or Outcomes: REVEAL-HF Michael O'Riordan November 19, 2021
News Conference News AHA 2021 Canagliflozin Improves Quality of Life in HF Patients Michael O'Riordan November 16, 2021
News Daily News Big Impact Anticipated With HFpEF Expansion of Sacubitril/Valsartan Label Todd Neale September 20, 2021
News Opinion Editor's Corner ESC 2021 ESC 2021: Trials, Guidelines, and Channel Surfing at This Year’s Virtual Congress Shelley Wood August 19, 2021
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for July 2021 Shelley Wood August 02, 2021
News Daily News Pneumonia in HF Patients Is Common, Lethal, and Preventable L.A. McKeown April 19, 2021
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for February 2021 Shelley Wood March 02, 2021
News Daily News New FDA Indication Opens Up Use of Sacubitril/Valsartan in HFpEF Todd Neale February 16, 2021